In Vivo Confocal Microscopy for Ocular Feature Evaluation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for eye inflammation, such as dry eye syndrome, lack effective methods to evaluate treatment efficacy and select appropriate therapies based on specific ocular physical features, leading to inadequate symptom relief and management.
Innovation Solution
Methods involving in vivo confocal microscopy to assess changes in ocular physical features like hyperreflective superficial epithelial cells, dendritic immune cells, and nerve structures in the cornea, allowing for personalized treatment selection and efficacy evaluation using topical steroids and immunosuppressive agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional treatments (artificial tears, oral antibiotics, cyclosporine, steroids) are prescribed for eye inflammation, then patients receive standard care, but there is no effective method to evaluate treatment efficacy or select appropriate therapies based on specific ocular physical features
Solution Approach 1:
The patent replaces conventional clinical evaluation methods with in vivo confocal microscopy technology. This optical imaging system uses fluorescent dyes and confocal optics to visualize and quantify ocular surface features (epithelial cells, dendritic cells, nerves) non-invasively, providing objective measurement data for treatment evaluation and therapy selection without requiring complex mechanical intervention.
2Adaptability or versatility
If in vivo confocal microscopy is used to assess ocular physical features, then personalized treatment selection and efficacy evaluation are enabled, but the complexity of the diagnostic system increases
Solution Approach 1:
The in vivo confocal microscopy system performs multiple functions: it visualizes epithelial cells, dendritic immune cells, and nerve structures; quantifies their density and morphology; and provides data for both treatment selection and efficacy monitoring. This multi-functional approach consolidates what would otherwise require multiple separate diagnostic procedures into a single versatile platform.
Solution Approach 2:
The system uses fluorescent dyes that bind to specific ocular surface structures, causing them to emit characteristic fluorescence signals. Different structures (epithelial cells, dendritic cells, nerves) exhibit distinct fluorescence patterns, allowing the system to differentiate and quantify multiple cell types and features simultaneously through optical signal analysis.
3Reliability
If treatment efficacy is evaluated based on changes in ocular physical features, then objective measurement is achieved, but the difficulty of detecting and measuring these features increases
Solution Approach 1:
Fluorescent dyes serve as intermediaries that bind to specific ocular surface structures (epithelial cells, dendritic cells, nerves) and amplify their optical signals. These dyes act as mediators between the microscopic structures and the detection system, enabling the confocal microscopy to visualize and quantify features that would otherwise be undetectable or difficult to measure with conventional imaging methods.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These methods enable targeted treatment approaches that correlate with changes in ocular features, improving symptom relief and treatment efficacy for eye inflammation conditions like dry eye syndrome.
Implementation Method 1
These methods require determining in an eye of a subject or obtaining (or reviewing previously obtained or recorded) medical information for the subject regarding one or more of (i) the number or percentage ofhyperreflective superficial epithelial cells present in the cornea
Data Source
AI summary
Provided herein are methods of evaluating efficacy of a treatment in a subject having eye inflammation (e.g., a subject having dry eye syndrome) and selecting a subject for participation in a clinical study. Also provided are methods of treating a subject having eye inflammation (e.g., a subject having dry eye syndrome).